Acorda Therapeutics Inc $37.88
|Trade Time:||Mar 07 08:10 PM Eastern Daylight Time|
|Change:||0.01 (0.03 %)|
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get ACOR Trend Analysis - it has outperformed the S&P 500 by 3%
|Date||Name||Title||Volume||Trade Price||Holding Change|
|12/05/2013||Sabella Lauren M||Exec. VP-Commercial Dvlpmnt||-8,797||$31.81||-41.50%|
|12/02/2013||Blight Andrew||Chief Scientifc Officer||-9,088||$33.51||-13.19%|
|12/02/2013||Carrazana Enrique J.||Chief Medical Officer||-1,640||$33.56||-4.80%|
|12/02/2013||COHEN RON||President and CEO||-18,125||$33.52||-3.78%|
|12/02/2013||LAWRENCE DAVID||Chief of Business Operations||-10,836||$33.51||-43.29%|
ACOR Stock Analysis
Get the four benefits of managed futures as outlined in this booklet.
Learn from Warren Buffett, George Soros and More!
Discover Investing Strategies that will Benefit Every Investor Today!